Thyra Imaging is a MedTech spin-off from the Medical University of Vienna, founded in 2026 with the goal of translating advanced imaging technology into real-world applications. Originally developed for astronomical telescopes, AO has been advanced towards clinical maturity at the Medical University of Vienna and is used in combination with OCT to enable a new level of resolution in retinal imaging. By integrating this technology with AI-driven analysis, Thyra Imaging enables new biomarkers and applications in research, drug development, and clinical practice.